TITLE

Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis

AUTHOR(S)
Marshall, N. S.; Barnes, M.; Travier, N.; Campbell, A. J.; Pierce, R. J.; McEvoy, R. D.; Neill, A. M.; Gander, P. H.
PUB. DATE
May 2006
SOURCE
Thorax;May2006, Vol. 61 Issue 5, p430
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the middle aged population. Meta-analyses of randomised controlled trials have shown that the severe presentation of the syndrome (apnoea hypopnoea index (AHI) >30/hour) is effectively treated with continuous positive airway pressure (CPAP). Until recently there have been insufficient data to determine whether CPAP improves sleepiness in the larger subgroup with mild to moderate OSAS (AHI 5–30/hour). Methods: A systematic search of Medline and a hand search identified seven randomised controlled trials where CPAP was compared with either a placebo or with conservative management in the treatment of mild to moderate OSAS (AHI 5–30/hour). All trials used the Epworth Sleepiness Scale (ESS), four used the Multiple Sleep Latency Test (MSLT), and three used the Maintenance of Wakefulness Test (MWT) to measure sleepiness. Results: Meta-analyses indicated that CPAP significantly reduced subjective daytime sleepiness (ESS) by 1.2 points (95% Cl 0.5 to 1 .9, p = 0.001), improved objective daytime wakefulness (MWT) by 2.1 minutes (95% Cl 0.5 to 3.7, p=0.011), but did not affect objective daytime sleepiness (MSLT, mean benefit -0.2 minutes, 95% Cl -1.0 to 0.6, p=0.6). The two significant effects were small (effect size <0.30). Conclusions: CPAP elicits small improvements in subjective sleepiness and objective wakefulness in people with mild to moderate OSAS. However, the effects on sleepiness are of limited clinical significance.
ACCESSION #
21039843

 

Related Articles

  • Novel Drug May Help Patients With Narcolepsy Maintain Wakefulness. Greb, Erik // Neurology Reviews;Sep2014, Vol. 22 Issue 9, p10 

    The article discusses a research study which suggests the efficacy of the experimental drug JZP-110 in treating patients with narcolepsy and excessive daytime sleepiness and in maintaining wakefulness, presented at the 28th Annual Meeting of the Associated Professional Sleep Societies. Data...

  • Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea. Marshall, N. S.; Neill, A. M.; Campbell, A. J.; Sheppard, D. S. // Thorax;May2005, Vol. 60 Issue 5, p427 

    Background: It is unclear whether continuous positive airway pressure (CPAP), the treatment of choice for severe obstructive sleep apnoea (OSA), is effective at improving outcomes in mild OSA. Methods: To help define the role of humidified CPAP in mild OSA, a randomised crossover study was...

  • Correction: Are Treatments More Effective than Placebos? A Systematic Review and Meta-Analysis. Howick, Jeremy; Friedemann, Claire; Tsakok, Maria; Watson, Robert; Tsakok, Teresa; Thomas, Jennifer; Perera, Rafael; Fleming, Susannah; Heneghan, Carl // PLoS ONE;1/15/2016, Vol. 11 Issue 1, p1 

    No abstract available.

  • Correlation between sleep parameters, physical activity and quality of life in somnolent moderate to severe obstructive sleep apnea adult patients. Verwimp, Jelke; Ameye, Lieveke; Bruyneel, Marie // Sleep & Breathing;Sep2013, Vol. 17 Issue 3, p1039 

    Purpose: Several symptoms are described in obstructive sleep apnea (OSA), including excessive daytime sleepiness, depressive mood and neurocognitive dysfunction. However, few studies examined the relationship between objective physical activity, quality of life and sleep parameters. The purpose...

  • Daytime sleepiness in Japanese patients with multiple system atrophy: prevalence and determinants. Shimohata, Takayoshi; Nakayama, Hideaki; Tomita, Masahiko; Ozawa, Tetsutaro; Nishizawa, Masatoyo // BMC Neurology;2012, Vol. 12 Issue 1, p130 

    Background: The recent SLEEMSA study that evaluated excessive daytime sleepiness (EDS) in Caucasian patients with multiple system atrophy (MSA) demonstrated that EDS was more frequent in patients (28%) than in healthy subjects (2%). However, the prevalence and determinants of EDS in other ethnic...

  • The effect of modafinil following acute CPAP withdrawal: a preliminary study. Stefanie Leung; Graham Starmer // Sleep & Breathing;Nov2008, Vol. 12 Issue 4, p359 

    Abstract  Daytime symptoms resulting from obstructive sleep apnea (OSA) include impaired neurobehavioural performance and increased sleepiness. Continuous positive airway pressure (CPAP) reduces these symptoms. However, even compliant users may temporarily withdraw from CPAP treatment...

  • Mandibular advancement appliances and obstructive sleep apnoea: a randomized clinical trial. Johnston, Chris D.; Gleadhill, Iain C.; Cinnamond, Michael J.; Gabbey, Jennifer; Burden, Donald J. // European Journal of Orthodontics;Jun2002, Vol. 24 Issue 3, p251 

    This randomized placebo-controlled cross-over trial assessed the effectiveness of a mandibular advancement appliance (MAA) in managing obstructive sleep apnoea (OSA). Twenty-one adults, with confirmed OSA, were provided with a maxillary placebo appliance and a MAA for 4~6 weeks each, in a...

  • Critical appraisal and meta-analysis of nasal surgery for obstructive sleep apnea. Li, Hsueh-Yu; Wang, Pa-Chun; Chen, Yu-Pin; Lee, Li-Ang; Fang, Tuan-Jen; Lin, Hsin-Ching // American Journal of Rhinology & Allergy;Jan/Feb2011, Vol. 25 Issue 1, p45 

    Background: Nasal surgery is commonly involved in surgical treatment for obstructive sleep apnea (OSA). The aim of this study was to investigate the outcomes of nasal surgery for OSA using evidence-based methodology. Methods: The MedLine database (1999∼2009) was searched for original...

  • Armodafinil. Garnock-Jones, Karly P.; Dhillon, Sohita; Scott, Lesley J. // CNS Drugs;2009, Vol. 23 Issue 9, p793 

    â–´ Armodafinil is the R-enantiomer of modafinil, a wake-promoting agent, that primarily affects areas of the brain involved in controlling wakefulness. â–´ Once-daily armodafinil was effective in improving wakefulness in adult patients with excessive sleepiness associated with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics